AI Health Tech Advances in Drug Discovery, Faces Challenges in Clinical Success
The use of AI in healthcare, particularly in drug discovery, is experiencing significant growth, yet it faces challenges in delivering cures for major diseases. At Novartis, AI was used to design millions of compounds for Huntington's disease, narrowing them down to promising candidates. Despite these advancements, no AI-discovered drug has received FDA approval, highlighting the gap between computational achievements and clinical success. Additionally, AI chatbots in healthcare pose risks, as they are not regulated as medical devices and can provide misleading advice, according to patient safety organizations. 
